Clinical trial · Interventional
Ultrasound Guided Serratus Anterior Plane Block Versus Ultrasound Guided Thoracic Epidural Analgesia
Ultrasound Guided Serratus Anterior Plane Block Versus Ultrasound Guided Thoracic Epidural Analgesia for Conservative Breast Surgery: A Comparative Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 9, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260909-000002
Summary
Brief summary (as posted)
Regional/local analgesic techniques are an important component of a multimodal analgesic strategy, with the aim of reducing opioid requirements and opioid-related adverse events. This change parallels quality improvement initiatives and the Enhanced Recover after Surgery. Breast conserving surgery with radiation therapy is today standard therapy for low grade breast cancer. It is safe and preferred therapeutic procedure in all early detected breast cancers ,because it provide the same level of overall survival rates as seen in patients treated with mastectomy ,have been found by several prospective and randomized studies and number of clinical trials .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bupivacaine 0.25% Injectable Solution | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Serratus anterior plane block Group
- description
- About 35 female patients diagnosed with breast malignancy subjected to Breast Conservative Surgery under general anesthesia by Ultrasound guided serratus anterior plane block anesthesia
- interventionNames
- Drug: Bupivacaine 0.25% Injectable Solution
- type
- ACTIVE_COMPARATOR
- label
- Thoracic epidural analgesia Group
- description
- About 35 female patients diagnosed with breast malignancy subjected to Breast Conservative Surgery under general anesthesia by ultrasound guided Thoracic Epidural Analgesia
- interventionNames
- Drug: Bupivacaine 0.25% Injectable Solution
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * patients of the American Society of Anesthesiology physical status (І and ІІ) Female patients. * Female patients diagnosed with breast malignancy * Patients with Body weight: patients with body mass index less than 35. Exclusion Criteria: * Uncooperative patient, those with any contraindication for spinal or epidural anesthesia (systemic coagulopathy-local infection) * Patients with body mass index \>35 * Patients with chronic obstructive pulmonary disease * Patients with anatomic abnormalities * Patients with allergy to study drugs
References
Publications (0)
Data not yet available